411 related articles for article (PubMed ID: 8871640)
1. Induction of apoptosis by anti-CD3 epsilon F(ab')2 in antigen receptor transgenic murine T cells activated by specific peptide.
Yu XZ; Zhu L; Davis JE; Tso JY; Hansen JA; Anasetti C
J Immunol; 1996 Oct; 157(8):3420-9. PubMed ID: 8871640
[TBL] [Abstract][Full Text] [Related]
2. Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction.
Hirsch R; Archibald J; Gress RE
J Immunol; 1991 Oct; 147(7):2088-93. PubMed ID: 1833451
[TBL] [Abstract][Full Text] [Related]
3. Lck is required for activation-induced T cell death after TCR ligation with partial agonists.
Yu XZ; Levin SD; Madrenas J; Anasetti C
J Immunol; 2004 Feb; 172(3):1437-43. PubMed ID: 14734719
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of susceptibility to Fas-mediated apoptosis of TH1 cells by nonmitogenic anti-CD3epsilon F(ab')2.
Yu XZ; Anasetti C
Transplantation; 2000 Jan; 69(1):104-12. PubMed ID: 10653388
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD3 epsilon F(ab')2 prevents graft-versus-host disease by selectively depleting donor T cells activated by recipient alloantigens.
Yu XZ; Bidwell SJ; Martin PJ; Anasetti C
J Immunol; 2001 May; 166(9):5835-9. PubMed ID: 11313428
[TBL] [Abstract][Full Text] [Related]
6. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation.
Ledbetter JA; June CH; Martin PJ; Spooner CE; Hansen JA; Meier KE
J Immunol; 1986 Jun; 136(11):3945-52. PubMed ID: 3084650
[TBL] [Abstract][Full Text] [Related]
7. Anti-CD3 epsilon F(ab')2 fragments inhibit T cell expansion in vivo during graft-versus-host disease or the primary immune response to nominal antigen.
Blazar BR; Jenkins MK; Taylor PA; White J; Panoskaltsis-Mortari A; Korngold R; Vallera DA
J Immunol; 1997 Dec; 159(12):5821-33. PubMed ID: 9550378
[TBL] [Abstract][Full Text] [Related]
8. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4.
Kearney ER; Walunas TL; Karr RW; Morton PA; Loh DY; Bluestone JA; Jenkins MK
J Immunol; 1995 Aug; 155(3):1032-6. PubMed ID: 7543510
[TBL] [Abstract][Full Text] [Related]
9. Uncoupling IL-2 production from apoptosis and TNF production by changing the signal through the TCR.
Glickstein L; Macphail S; Stutman O
J Immunol; 1996 Mar; 156(6):2062-7. PubMed ID: 8690893
[TBL] [Abstract][Full Text] [Related]
10. Deficient CD4+ T cell proliferation in the class 1 MHC-restricted 2C TCR-transgenic mouse.
Chen FL; Kung JT
J Immunol; 1996 Mar; 156(6):2036-44. PubMed ID: 8690890
[TBL] [Abstract][Full Text] [Related]
11. Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells.
Hirsch R; Gress RE; Pluznik DH; Eckhaus M; Bluestone JA
J Immunol; 1989 Feb; 142(3):737-43. PubMed ID: 2521507
[TBL] [Abstract][Full Text] [Related]
12. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
13. Activation of T cells by cross-linking an anti-CD3 antibody with a second anti-T cell antibody: mechanism and subset-specific activation.
Walker C; Bettens F; Pichler WJ
Eur J Immunol; 1987 Jun; 17(6):873-80. PubMed ID: 2439351
[TBL] [Abstract][Full Text] [Related]
14. Extinction of IL-12 signaling promotes Fas-mediated apoptosis of antigen-specific T cells.
Marth T; Zeitz M; Ludviksson BR; Strober W; Kelsall BL
J Immunol; 1999 Jun; 162(12):7233-40. PubMed ID: 10358170
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of costimulator signals and interleukin-2 on T cell receptor-mediated cell death of resting and activated CD4+ murine splenic T cells.
Cohen DJ; Tian Y; Ooi BS; Henkart PA
Transplantation; 1996 Feb; 61(3):486-91. PubMed ID: 8610365
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of I-Ad-, but not Db-restricted peptide-induced thymic apoptosis by glucocorticoid receptor antagonist RU486 in T cell receptor transgenic mice.
Xue Y; Murdjeva M; Okret S; McConkey D; Kiuossis D; Jondal M
Eur J Immunol; 1996 Feb; 26(2):428-34. PubMed ID: 8617314
[TBL] [Abstract][Full Text] [Related]
17. In vivo administration of anti-CD3 monoclonal antibodies or immunotoxins in murine recipients of allogeneic T cell-depleted marrow for the promotion of engraftment.
Blazar BR; Hirsch R; Gress RE; Carroll SF; Vallera DA
J Immunol; 1991 Sep; 147(5):1492-503. PubMed ID: 1831826
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility and resistance to antigen-induced apoptosis in the thymus of transgenic mice.
Tarazona R; Williams O; Moskophidis D; Smyth LA; Tanaka Y; Murdjeva M; Wack A; Mamalaki C; Kioussis D
J Immunol; 1998 Jun; 160(11):5397-403. PubMed ID: 9605140
[TBL] [Abstract][Full Text] [Related]
19. Contrasting in vivo effects on T helper cell functions induced by mitogenic (intact) versus nonmitogenic (F(ab')2) anti-CD3 monoclonal antibody.
Sawchuk SS; Gates R; Hirsch R
Transplantation; 1995 Dec; 60(11):1331-7. PubMed ID: 8525530
[TBL] [Abstract][Full Text] [Related]
20. TCR-gamma delta cells in CD3 zeta-deficient mice contain Fc epsilon RI gamma in the receptor complex but are specifically unresponsive to antigen.
Khattri R; Sperling AI; Qian D; Fitch FW; Shores EW; Love PE; Bluestone JA
J Immunol; 1996 Sep; 157(6):2320-7. PubMed ID: 8805629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
